Trial intelligence / Profile preview

Steady-state pharmacokinetics of tigecycline in critically ill patients with lower respiratory tract infection

2007-000506-78Phase 3Terminated

Sponsor
Hannover Clinical Trial Center
Start
Mar 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of tigecycline in pulmonary infection, sponsored by Hannover Clinical Trial Center. Primary endpoint: Steady-state pharmacokinetics of tigecycline on day 3. Started Mar 2007; status: terminated.

02

Drugs

tigecycline
03

Conditions

pulmonary infection

Beyond the preview

Go deeper on 2007-000506-78.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000506-78.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call